E.E. Geduld’s Opexa Therapeutics, Inc. OPXAW Stock Holding History

E.E. Geduld’s Portfolio OPXAW Stock Details OPXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1K	Hold	60,200	–	–	﹤0.01%	177
2016 Q3	$6K	Buy	+60,200	New	+$5.51K	0.01%	181
2016 Q2	–	Sell	-60,200	Closed	-$4K	–	199
2016 Q1	$4K	Hold	60,200	–	–	0.01%	148
2015 Q4	$6K	Hold	60,200	–	–	﹤0.01%	170
2015 Q3	$7K	Buy	+60,200	New	+$7.31K	0.01%	187

Other funds holding OPXAW

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

E.E. Geduld's OPXAW Position: Q4 2016 in Review

E.E. Geduld held its Opexa Therapeutics, Inc. (OPXAW) position steady in Q4 2016 at 60,200 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #177.

E.E. Geduld first reported a position in OPXAW in Q3 2015 and has held it in 5 quarters since. The position peaked at $7K in Q3 2015. 4 funds tracked by Wall St. Rank hold OPXAW as of Q4 2016.

E.E. Geduld held 60,200 shares of Opexa Therapeutics, Inc. worth $1K as of Q4 2016.
E.E. Geduld left its Opexa Therapeutics, Inc. share count unchanged in Q4 2016.
Opexa Therapeutics, Inc. made up ﹤0.01% of E.E. Geduld's portfolio in Q4 2016, its #177 holding.
E.E. Geduld first reported a position in Opexa Therapeutics, Inc. in Q3 2015 and has held it in 5 quarters since.
E.E. Geduld's Opexa Therapeutics, Inc. position peaked at $7K in Q3 2015.
4 funds tracked by Wall St. Rank held Opexa Therapeutics, Inc. as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.